Qubit To Power British Heart Foundation’s Journey To Personalisation

By on    Computer & Software, Picture Gallery  

Qubit To Power British Heart Foundation’s Journey To Personalisation

[LONDON – AUGUST 23 2017] The British Heart Foundation, the single biggest funder of cardiovascular research in the UK, has chosen Qubit, the leader in delivering highly persuasive personalisation at scale, to provide a more personalised experience for their website visitors.

The charity will use Qubit’s technology to drive volunteer sign ups, increase donations, and make it easier for visitors to access the right content. This will include tailoring the website’s wealth of online resources an

Lexington Biosciences Commences Trading on OTC Markets as LXGTF and Introduces Key Board Members

By on    Networking, Picture Gallery  

Lexington Biosciences Commences Trading on OTC Markets as LXGTF and Introduces Key Board Members

VANCOUVER, BC — (Marketwired) — 07/06/17 — (CSE: LNB) (CNSX: LNB) (OTC PINK: LXGTF) (the "Company" or "Lexington"), a development-stage medical device company operating within the healthcare industry, is pleased to announce it has met the compliance requirements of the Financial Industry Regulatory Authority (FINRA) and has initiated price quotation on OTC Link under the ticker symbol: LXGTF.In related news, the Company wishes to introduce two members of its Board; Mr. R

Lexington Biosciences Introduces President and Board Chair

By on    Networking, Picture Gallery  

Lexington Biosciences Introduces President and Board Chair

VANCOUVER, BC — (Marketwired) — 05/23/17 — (CSE: LNB) (LNB.CN) (CNSX: LNB) (the "Company" or "Lexington"), a development-stage medical device company operating within the healthcare industry, is pleased to introduce and welcome Mr. Eric Willis as Company President, and Mr. Doug Janzen as Board Chairman.Mr. Willis is a twenty plus year veteran of the healthcare technology industry with a passion for working closely with clinicians to bring products from concept to market.